CXCL11 AND SMICA AS PREDICTIVE BIOMARKERS FOR EFFICACY OF ANTI-CTLA4 IMMUNOTHERAPY Application WO-2016127052-A1 World Intellectual Property Organisation (WIPO) 11 Aug 2016